These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32927400)
1. Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity. Torres-Machorro A; Anguiano-Álvarez VM; Grimaldo-Gómez FA; Rodríguez-Zanella H; Cortina de la Rosa E; Mora-Canela S; Lerma C; García-Cruz E; Ramos-Enriquez Á; Ramirez-Marroquin S; Izaguirre-Ávila R; Rojas-Velasco G Thromb Res; 2020 Dec; 196():268-271. PubMed ID: 32927400 [TBL] [Abstract][Full Text] [Related]
2. Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19. Zermatten MG; Pantet O; Gomez F; Schneider A; Méan M; Mazzolai L; Hugli O; Bart PA; Papadimitriou-Olivgeris M; Alberio L; Thromb Res; 2020 Dec; 196():222-226. PubMed ID: 32916564 [No Abstract] [Full Text] [Related]
3. Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy. Longhitano Y; Racca F; Zanza C; Piccioni A; Audo A; Muncinelli M; Santi R; Kozel D; Geraci C; Taverna M; Bonato V; Cassini F; Franceschi F Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9154-9160. PubMed ID: 32965007 [TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in non-critically ill patients with COVID-19 infection. Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275 [TBL] [Abstract][Full Text] [Related]
5. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Siegal DM; Gross PL Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1958-1960. PubMed ID: 32762455 [No Abstract] [Full Text] [Related]
6. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Linnemann B; Bauersachs R; Grebe M; Klamroth R; Müller O; Schellong S; Lichtenberg M Vasa; 2020 Jun; 49(4):259-263. PubMed ID: 32501145 [No Abstract] [Full Text] [Related]
7. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm. Spyropoulos AC; Weitz JI Circulation; 2020 Jul; 142(2):129-132. PubMed ID: 32658609 [No Abstract] [Full Text] [Related]
8. Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough? de Montmollin E; Faille D; Andrieu V; Ajzenberg N; Timsit JF J Infect; 2021 May; 82(5):e20-e22. PubMed ID: 33549626 [No Abstract] [Full Text] [Related]
9. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients. Roncon L; Zuin M; Zonzin P Thromb Res; 2020 Jun; 190():102. PubMed ID: 32335420 [No Abstract] [Full Text] [Related]
10. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? Cattaneo M; Bertinato EM; Birocchi S; Brizio C; Malavolta D; Manzoni M; Muscarella G; Orlandi M Thromb Haemost; 2020 Aug; 120(8):1230-1232. PubMed ID: 32349132 [No Abstract] [Full Text] [Related]
11. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Epelbaum O Ann Intern Med; 2020 Dec; 173(12):1029-1030. PubMed ID: 33316198 [No Abstract] [Full Text] [Related]
12. Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship? Stessel B; Peeters J; Bruckers L; Nulens M; Callebaut I; Poelaert J; Dubois J Thromb Res; 2021 Oct; 206():139-141. PubMed ID: 34479130 [No Abstract] [Full Text] [Related]
13. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Siguret V; Voicu S; Neuwirth M; Delrue M; Gayat E; Stépanian A; Mégarbane B Thromb Res; 2020 Nov; 195():74-76. PubMed ID: 32663703 [TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines. Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies. Di Minno A; Ambrosino P; Calcaterra I; Di Minno MND Semin Thromb Hemost; 2020 Oct; 46(7):763-771. PubMed ID: 32882719 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship. Pavoni V; Gianesello L Thromb Res; 2020 Oct; 194():190-191. PubMed ID: 32788115 [No Abstract] [Full Text] [Related]
17. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications. Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009 [TBL] [Abstract][Full Text] [Related]
18. Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations. Flaczyk A; Rosovsky RP; Reed CT; Bankhead-Kendall BK; Bittner EA; Chang MG Crit Care; 2020 Sep; 24(1):559. PubMed ID: 32938471 [TBL] [Abstract][Full Text] [Related]
19. [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data]. Zerwes S; Hernandez Cancino F; Liebetrau D; Gosslau Y; Warm T; Märkl B; Hyhlik-Dürr A Chirurg; 2020 Jul; 91(7):588-594. PubMed ID: 32504106 [TBL] [Abstract][Full Text] [Related]